首页> 外文期刊>Journal of Clinical Microbiology >New Approach for Serological Testing for Leptospirosis by Using Detection of Leptospira Agglutination by Flow Cytometry Light Scatter Analysis
【24h】

New Approach for Serological Testing for Leptospirosis by Using Detection of Leptospira Agglutination by Flow Cytometry Light Scatter Analysis

机译:流式细胞仪光散射分析检测钩端螺旋体凝集的血清学检测钩端螺旋体的新方法

获取原文

摘要

Leptospirosis is considered an important reemerging infectious disease worldwide. The standard and most widespread method for the diagnosis of leptospirosis is the microscopic agglutination test (MAT). This test is laborious and time-consuming, and the interpretation of the results is subjective. In the present work we describe an application of flow cytometry (FCM) as a tool for the serological diagnosis of leptospirosis. The analysis is based on the sensitivity of FCM to the size and shape of the bacteria analyzed by measurement of light scatter parameters: forward scatter (FSC) and side scatter (SSC). The addition of positive serum to an infecting leptospiral serovar results in a shift of the light scatter parameter to a different location with higher FSC and SSC values, indicating the formation of leptospiral aggregates. By using immunofluorescent staining, we have shown that the large particles formed are the agglutinated leptospires. Quantification of the agglutination process has been achieved by calculating an agglutination factor (Af), based on changes in the light scatter parameters measured by FCM. Af enables us to determine the specificity of the serological reaction of the patient serum with each leptospiral serovar. In this work, 27 serum samples from 18 leptospirosis patients were tested by both the MAT and the FCM techniques, in which each serum sample was tested against 13 serovars. Twenty-six human serum samples derived from patients with a variety of other defined illnesses were used as negative controls and enabled us to define the Af threshold value as <9.3 for negative patients, while any value higher than that would be a positive result for leptospirosis. Compared to MAT, the FCM technique was found to be more specific and sensitive, especially in identifying the serogroup in the acute phase of the disease. The whole process was found to be rapid and took less than 1.5 h. Moreover, FCM analysis is objective and can be automated for the handling of large numbers of samples.
机译:钩端螺旋体病在世界范围内被认为是一种重要的新兴传染病。诊断钩端螺旋体病的标准且最广泛的方法是显微镜凝集试验(MAT)。该测试费力且费时,并且结果的解释是主观的。在当前的工作中,我们描述了流式细胞仪(FCM)作为钩端螺旋体病血清学诊断工具的应用。该分析基于FCM对通过测量光散射参数(前向散射(FSC)和侧向散射(SSC))分析的细菌的大小和形状的敏感性。向感染的钩端螺旋体血清型中添加阳性血清会导致光散射参数移动到具有较高FSC和SSC值的不同位置,表明钩端螺旋体聚集体的形成。通过使用免疫荧光染色,我们已经显示形成的大颗粒是凝集的钩藤螺。通过基于FCM测量的光散射参数的变化来计算凝集因子( A f ),可以实现对凝集过程的量化。 A f 使我们能够确定患者血清与每种钩端螺旋体血清型的血清学反应的特异性。在这项工作中,通过MAT和FCM技术对18例钩端螺旋体病患者的27份血清样品进行了检测,其中每种血清样品均针对13种血清进行了检测。来自其他各种疾病的患者的26份人血清样本用作阴性对照,使我们能够将 A f 阈值定义为<9.3(阴性)对患者而言,任何高于此值的值都将是钩端螺旋体病的阳性结果。与MAT相比,FCM技术被发现更具特异性和敏感性,特别是在疾病急性期的血清群识别中。发现整个过程是快速的,花费了不到1.5小时。而且,FCM分析是客观的,可以自动化处理大量样品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号